Company profile
James E. Wagner Cultivation Corporation
OTC: JWCAF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Kitchener, ONReports USD
#825 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), workforce scale · ↓ disclosure history, market scale
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
+310.1%
Net income (FY)
-$5.3M
Employees
160
as of 2026-08-29
Market cap
$10.9k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.6M2.1M CAD2019
Net income-$5.3M-7.0M CAD2019
Operating income-$7.0M-9.2M CAD2019
Total assets$16.5M21.9M CAD2019
Liabilities$7.9M10.5M CAD2019
Equity$8.6M11.4M CAD2019
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is James E. Wagner Cultivation Corporation’s revenue?
James E. Wagner Cultivation Corporation booked $1.6M in FY2019 revenue, growing 3478% year over year — faster than 98% of Healthcare companies we track, at a -327.9% net margin.
Peers · Healthcare
Clearside Biomedical, Inc.——Rani Therapeutics Holdings, Inc.41DEBR Systems, Inc.34DCannabis Global Inc.——BG Medicine, Inc.——Acura Pharmaceuticals, Inc.——Key facts
CEONathaniel Woodworth
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersKitchener, ON
ExchangeOTC: JWCAF
Employees160
IPO date2018-06-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.